Advertisement
A new study in mice hints at the success of a vaccine against the herpes simplex virus. The research was published online March 9 in eLife.

HSV-2 Vaccine Shows Promise in Experimental Research

0
Study in mice hints at the success of a vaccine against the virus
A monthly educational intervention paired with a web-based quality improvement tool is feasible for increasing the proportion of inappropriate proton pump inhibitor prescriptions discontinued at hospital discharge

Educational Intervention Can Cut Inappropriate PPI Prescriptions

0
Increase in proportion of PPIs discontinued at hospital discharge after intervention implementation
Cresemba (isavuconazonium sulfate) has been approved by the U.S. Food and Drug Administration to treat invasive aspergillosis and invasive mucormycosis

FDA Approves Cresemba for Serious Fungal Infections

0
New drug targets cell walls of the fungi; available in oral and intravenous formulations
National hospital rating systems are rarely in agreement

National Hospital Rating Systems Rarely in Agreement

0
None of the hospitals rated as high performer on all four national rating systems
Extended pre-quit bupropion is associated with reduced smoking behavior during the pre-quit period and improved short-term abstinence rates

Extended Pre-Cessation Bupropion Helps Smokers Quit

0
Reduces smoking behavior during the pre-quit period; improves short-term abstinence rates
A new study finds that treating moderate to severe depression with antidepressants may have an added bonus: reducing cardiovascular risks. The findings are scheduled to be presented March 15 at the annual meeting of the American College of Cardiology

ACC: Antidepressants May Help Reduce Cardiovascular Risk

0
Reduced risk of death, heart disease, stroke in patients with moderate to severe depression
Most lung and colorectal cancer patients involve family members in treatment decisions

Most Cancer Patients Involve Family in Treatment Decisions

0
Chinese-speaking Asians, Spanish-speaking Hispanics more often share decisions with family
The U.S. Food and Drug Administration has approved Zarxio (filgrastim-sndz)

FDA Approves First Biosimilar Drug in U.S.

0
Zarxio is highly similar to long-sanctioned cancer drug
For patients with breast cancer

Goserelin Protects Against Ovarian Failure in Breast Cancer

0
Randomized trial shows reduction in ovarian failure and more pregnancy for chemo + goserelin
A vaccine for hepatitis E provides protection from the virus for at least 4.5 years

Vaccine May Provide Some Protection From Hepatitis E

0
Immunization offers nearly five years of protection, researchers say